Literature DB >> 18474812

Endothelial dysfunction and cytomegalovirus replication in pediatric heart transplantation.

Jacob Simmonds1, Matthew Fenton, Catherine Dewar, Elizabeth Ellins, Clare Storry, David Cubitt, John Deanfield, Nigel Klein, Julian Halcox, Michael Burch.   

Abstract

BACKGROUND: Cardiac allograft vasculopathy is the major limiting factor to the long-term success of pediatric heart transplantation. Cytomegalovirus (CMV) has been shown to be a significant risk factor for the development of cardiac allograft vasculopathy. Recent work has demonstrated CMV DNA in leukocytes in the absence of direct allograft infection, suggesting that vascular changes may not be limited to the allograft. METHOD AND
RESULTS: Systemic arterial endothelial function was assessed with high-resolution ultrasound to determine brachial artery flow-mediated dilation in 50 pediatric heart transplant recipients (8 to 17 years of age; 27 male). Patients were separated into 2 groups according to CMV status: those without evidence of CMV replication after transplantation (n=38; 19 male) and patients with evidence of viremia after transplantation (n=12; 8 male). No patient had detectable viremia at the time of study. Flow-mediated dilation was significantly impaired in patients with evidence of CMV replication after transplantation (6.64+/-1.12%, mean+/-SE) compared with those without (9.48+/-0.56%; P=0.02). This difference remained after adjustment for age, time since transplantation, and medication. Pretransplantation recipient and donor CMV status and traditional CMV risk were not associated with flow-mediated dilation.
CONCLUSIONS: CMV replication after cardiac transplantation is associated with chronic endothelial dysfunction in the systemic circulation in children. The implication for both systemic and coronary vascular health requires prospective evaluation.

Entities:  

Mesh:

Year:  2008        PMID: 18474812     DOI: 10.1161/CIRCULATIONAHA.107.718874

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Productive Cytomegalovirus Infection Is Associated With Impaired Endothelial Function in ST-Elevation Myocardial Infarction.

Authors:  Anna Lebedeva; Elena Maryukhnich; Jean-Charles Grivel; Elena Vasilieva; Leonid Margolis; Alexander Shpektor
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

2.  Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients.

Authors:  Manisha Patel; Martha Stefanidou; Caroline B Long; Melissa J Fazzari; Lydia Tesfa; Marcela Del Rio; Jacqueline Lamour; Rosanna Ricafort; Rebecca P Madan; Betsy C Herold
Journal:  Pediatr Transplant       Date:  2011-07-18

3.  Relation of high cytomegalovirus antibody titres to blood pressure and brachial artery flow-mediated dilation in young men: the Cardiovascular Risk in Young Finns Study.

Authors:  A Haarala; M Kähönen; T Lehtimäki; J Aittoniemi; J Jylhävä; N Hutri-Kähönen; L Taittonen; T Laitinen; M Juonala; J Viikari; O T Raitakari; M Hurme
Journal:  Clin Exp Immunol       Date:  2012-02       Impact factor: 4.330

Review 4.  New insights into postrenal transplant hemolytic uremic syndrome.

Authors:  Julien Zuber; Moglie Le Quintrec; Rebecca Sberro-Soussan; Chantal Loirat; Véronique Frémeaux-Bacchi; Christophe Legendre
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

Review 5.  Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives.

Authors:  Jeng-Jiann Chiu; Shu Chien
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

6.  Evolving concepts and treatment strategies for cardiac allograft vasculopathy.

Authors:  Rodolfo Denadai Benatti; David O Taylor
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-01

Review 7.  Endothelial dysfunction and cardiac allograft vasculopathy.

Authors:  Monica Colvin-Adams; Nonyelum Harcourt; Daniel Duprez
Journal:  J Cardiovasc Transl Res       Date:  2012-11-08       Impact factor: 4.132

8.  Anticytomegalovirus CD4+ T Cells Are Associated With Subclinical Atherosclerosis in Persons With HIV.

Authors:  Celestine N Wanjalla; Mona Mashayekhi; Samuel Bailin; Curtis L Gabriel; Leslie M Meenderink; Tecla Temu; Daniella T Fuller; Liang Guo; Kenji Kawai; Renu Virmani; Cathy Jenkins; Chike O Abana; Christian M Warren; Rama Gangula; Rita Smith; Meena S Madhur; Aloke V Finn; Alexander H Gelbard; Yan Ru Su; Matthew J Tyska; Spyros A Kalams; David G Harrison; Simon A Mallal; Tarek S Absi; Joshua A Beckman; John R Koethe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2021-02-11       Impact factor: 8.311

9.  Cytomegalovirus seropositivity is associated with increased arterial stiffness in patients with chronic kidney disease.

Authors:  Nadezhda A Wall; Colin D Chue; Nicola C Edwards; Tanya Pankhurst; Lorraine Harper; Richard P Steeds; Sarah Lauder; Jonathan N Townend; Paul Moss; Charles J Ferro
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

10.  Hydrogen Peroxide Induce Human Cytomegalovirus Replication through the Activation of p38-MAPK Signaling Pathway.

Authors:  Jun Xiao; Jiang Deng; Liping Lv; Qiong Kang; Ping Ma; Fan Yan; Xin Song; Bo Gao; Yanyu Zhang; Jinbo Xu
Journal:  Viruses       Date:  2015-06-04       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.